Cargando…
Effectiveness, tolerability and safety of azithromycin 1% in DuraSite(®) for acute bacterial conjunctivitis
PURPOSE: Bacterial eye infections are commonly treated with topical antibiotics, despite limited evidence of effectiveness. Azithromycin 1% in DuraSite(®) is a new formulation of azithromycin in a gel polymer designed for use in acute bacterial conjunctivitis. METHODS: We conducted systematic search...
Autores principales: | McLean, Susannah, Sheikh, Aziz |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875716/ https://www.ncbi.nlm.nih.gov/pubmed/20517467 |
Ejemplares similares
-
Fluoroquinolones compared to 1% azithromycin in DuraSite(®) for bacterial conjunctivitis
por: Lichtenstein, Steven J, et al.
Publicado: (2008) -
Azithromycin in DuraSite(®) for the treatment of blepharitis
por: Luchs, Jodi
Publicado: (2010) -
Response to correspondence from Lichtenstein and Granet Re: Fluoroquinolones compared to 1% azithromycin in DuraSite(®) for bacterial conjunctivitis
por: Friedlaender, Mitchell H, et al.
Publicado: (2008) -
An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite(®)
por: Granet, David, et al.
Publicado: (2007) -
Clinical development of 1% azithromycin in DuraSite(®), a topical azalide anti-infective for ocular surface therapy
por: Friedlaender, Mitchell H, et al.
Publicado: (2007)